Rohit Dev Mehta
Vorstandsvorsitzender bei HORIZONS GROWTH TRI ETF PORTFOLIO
Ursprung des Netzwerks ersten Grades von Rohit Dev Mehta
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
VenGrowth Capital Partners, Inc.
 VenGrowth Capital Partners, Inc. Investment ManagersFinance Founded in 1982, VenGrowth Capital Partners, Inc. is a private equity and venture capital firm located in Toronto, Ontario. The firm is a subsidiary of Covington Capital Corp. They manage retail and institutional assets.
30
| Extinct | Investment Managers | 30 |
Canadian ETF Association
 Canadian ETF Association Miscellaneous Commercial ServicesCommercial Services Canadian ETF Association operates as an association which provides information, education and access to resources on ETF investing in Canada. The company is headquartered in Toronto, Canada.
11
| Private Company | Miscellaneous Commercial Services | 11 |
FA Administration Services, Inc.
2
| Private Company | 2 | |
Horizons ETFs Management (Canada), Inc.
 Horizons ETFs Management (Canada), Inc. Investment ManagersFinance Global X Investments Canada, Inc. (Global X) is an investment management firm headquartered in Toronto, Canada. Formerly known as Horizons ETFs Management (Canada), Inc., the firm was founded by Adam Felesky in 2005 and is a wholly owned subsidiary of Mirae Asset Global Investments Co. Ltd. in South Korea. Global X offers a suites of exchange traded funds in Canada. The Global X product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions.
2
| Subsidiary | Investment Managers | 2 |
| Mutual Fd-ETF | Investment Trusts/Mutual Funds | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rohit Dev Mehta
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MICROSOFT CORPORATION | Packaged Software | Corporate Officer/Principal Corporate Officer/Principal | |
| NORTEL NETWORKS CORPORATION (USA) | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Director/Board Member | |
IceFyre Semiconductor, Inc.
 IceFyre Semiconductor, Inc. SemiconductorsElectronic Technology IceFyre Semiconductor, Inc. provides fabless semiconductor products. Its products include integrated circuits, wireless, WiFi, and WLAN devices. The company was founded by Doug Sanderson in 2001 and is located in Kanata, Canada. | Semiconductors | Director/Board Member Director/Board Member | |
Xceed Molecular Corp.
 Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Medical Specialties | Director/Board Member Director/Board Member | |
| PRECIOUS METALS AND MINING TRUST | Investment Trusts/Mutual Funds | Director of Finance/CFO Director/Board Member | |
JovFunds Management, Inc.
 JovFunds Management, Inc. Financial ConglomeratesFinance JovFunds Management, Inc. is a fund distributor located in Toronto, Ontario. The firm is a subsidiary of 8689784 Canada, Inc. and their ultimate parent is Industrial Alliance Insurance & Financial Services (TSE: IAG). The firm specializes in the isolation of alpha and beta, separating the active returns of portfolio management (alpha) from the passive returns of market performance (beta). They provide tax-efficient, risk-adjusted strategies through a variety of ETFs, structured products, alternative investments and mutual funds | Financial Conglomerates | Director/Board Member | |
| SENTRY SELECT PRIMARY METALS CORP. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Rotman School of Management | College/University | Masters Business Admin | |
| CI FINANCIAL CORP. | Investment Managers | Director of Finance/CFO General Counsel | |
Marret High Yield Strategies Fund
 Marret High Yield Strategies Fund Investment Trusts/Mutual FundsMiscellaneous Marret High Yield Strategies Fund operates as a closed-end investment fund. The company was founded on May 28, 2009 and is headquartered in Toronto, Canada. | Investment Trusts/Mutual Funds | Director of Finance/CFO Director/Board Member | |
| MARRET MULTI-STGY UN | Investment Trusts/Mutual Funds | Director of Finance/CFO Director/Board Member | |
| JFT STRATEGIES FUND | Investment Trusts/Mutual Funds | President Director/Board Member | |
| HORIZONS PIPELINES & ENERGY SERVICES INDEX ETF | Investment Trusts/Mutual Funds | Chief Investment Officer | |
CI Investments, Inc.
 CI Investments, Inc. Investment ManagersFinance CI Investments, Inc. is a Canadian mutual fund manager headquartered in Toronto, Ontario. The firm was founded in 1965 as CI Mutual Funds, Inc. and adopted the name CI Investments in June 2005 to reflect its diverse line-up of investment options, including mutual funds, segregated funds, asset allocation programs, structured products and other alternative investments. They are a subsidiary of CI Financial Corp. (TSX: CIX). CI Investments manages money on behalf of Canadian investors and provide them with an increasingly comprehensive Canadian, global and industry funds. | Investment Managers | Director of Finance/CFO General Counsel | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree | |
| Queen's University | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Masters Business Admin Graduate Degree Undergraduate Degree Masters Business Admin | |
| University of Ottawa | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Masters Business Admin Graduate Degree Doctorate Degree | |
| The University of Waterloo | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| McMaster University | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Director/Board Member | |
Axela, Inc.
 Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member Director/Board Member | |
Interface Biologics, Inc.
 Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Information Technology Services | Director/Board Member Director/Board Member | |
Locationary, Inc.
 Locationary, Inc. Miscellaneous Commercial ServicesCommercial Services Locationary, Inc. provides mobile and web solutions to manage the world's local business places information. Its services include data origination, data cleaning, publisher ID mapping, and management of domestic and international local business places data in a cloud-based system. The company was founded in 2009 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Kaneq Bioscience Ltd.
 Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member | |
| The Schulich School of Business | College/University | Masters Business Admin Masters Business Admin | |
| CI FIRST ASSET CANADIAN REIT ETF | Real Estate Investment Trusts | Chief Executive Officer Director/Board Member | |
| CI INVESTMENT GRADE BOND ETF - DISTRIBUTING - CAD | Investment Trusts/Mutual Funds | President Director/Board Member | |
Cura-Can Health Corp.
 Cura-Can Health Corp. Medical/Nursing ServicesHealth Services Cura-Can Health Corp. offers cannabis and hemp based product development and associated clinical services. The company is headquartered in Calgary, Canada. | Medical/Nursing Services | Director of Finance/CFO | |
| CI GALAXY BITCOIN FUND | Investment Trusts/Mutual Funds | Chief Executive Officer Director/Board Member | |
| Apiary Therapeutics, Inc. | Director/Board Member | ||
| TVM Life Science Management, Inc. | Investment Managers | Private Equity Investor |
Statistik
International
| Kanada | 47 |
| Vereinigte Staaten | 5 |
Sektoral
| Miscellaneous | 15 |
| Finance | 10 |
| Consumer Services | 10 |
| Health Technology | 9 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 149 |
| Corporate Officer/Principal | 56 |
| Director of Finance/CFO | 42 |
| Undergraduate Degree | 29 |
| Private Equity Investor | 27 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Douglas Jamieson | 40 |
| Adam Chowaniec | 35 |
| Edward Kelterborn | 28 |
| Cynthia Lavoie | 23 |
| Jeffrey Courtney | 17 |
| Amar Varma | 15 |
| Frédéric Sweeney | 14 |
| Ken Yoon | 13 |
| Peter Carrescia | 12 |
| Graham Matthews | 12 |
| Michelle McBane | 12 |
| Steven James Hawkins | 11 |
| Michael Wolfe | 10 |
| Graham McBride | 9 |
| Pat Chiefalo | 8 |
- Börse
- Insiders
- Rohit Dev Mehta
- Unternehmensverbindungen